Rubicon Research has launched its initial public offering amid strong investor interest. This article covers the price band, lot size, subscription levels, grey market premium (GMP), allotment process, and key points to consider before investing.
About the IPO
Rubicon Research Limited is a pharmaceutical company focused on developing, manufacturing, and licensing specialty formulations. The company’s IPO includes a combination of a fresh issue and an offer-for-sale (OFS), aimed at reducing debt, supporting capacity expansion, and enabling shareholder exits.
IPO Name, Price Band & Lot Size
- IPO Name: Rubicon Research Ltd.
- Price Band: ₹461 to ₹485 per share
- Lot Size: 30 shares per lot (minimum investment ₹14,550)
IPO Date & Timeline
- Issue Opens: October 9, 2025
- Issue Closes: October 13, 2025
- Basis of Allotment: October 14, 2025 (tentative)
- Credit to Demat / Refunds: October 15, 2025
- Expected Listing Date: October 16, 2025 (NSE and BSE)
GMP (Grey Market Premium) & Subscription Details
As per market observers, the Rubicon Research IPO GMP today is around ₹80 over the upper price band, indicating an expected listing price of approximately ₹565 per share. This shows positive sentiment in the grey market, though actual listing performance depends on demand on the exchanges.
On Day 1, the IPO was subscribed about 0.51 times, receiving bids for around 84.57 lakh shares against 1.64 crore shares offered. The Qualified Institutional Buyers (QIB) portion was still opening, while retail investors and non-institutional investors (NII) showed healthy participation. Subscription numbers are expected to rise over the remaining days.
Anchor Investment & Issue Size
- Total Issue Size: ₹1,377.50 crore
- Fresh Issue: ₹500 crore
- Offer-for-Sale (OFS): ₹877.50 crore
- Anchor Investors: The company raised ₹619 crore from anchor investors before the issue opened, signaling strong institutional interest.
Corporate Events, Dividend & Bonus
Currently, there is no declared dividend or bonus related to the IPO. Once the company lists, any future dividend or bonus decision will depend on financial performance and board approval.
Stock Price & Multibagger Potential
Rubicon Research operates in the pharmaceutical and specialty formulation segment, which has consistent demand and export potential. While the GMP suggests a strong debut, investors should note that GMP is speculative. Long-term returns will depend on profitability, R&D strength, and global market presence — making it a potential long-term growth stock if executed well.
Steps to Check IPO Allotment Status
Investors can check their Rubicon Research IPO allotment status through the following methods:
- Visit the official registrar’s website (expected to be MUFG Intime India).
- Enter your PAN number, application ID, or DP/Client ID to check your status.
- You can also check via broker platforms like Upstox, HDFC Securities, Zerodha, or Groww once the allotment is finalized.
- BSE and NSE also offer a “Check Application Status” tool for IPO allotment updates.
Disclaimer
This article is meant for informational purposes only and should not be treated as investment advice. The Grey Market Premium (GMP) is unofficial and speculative. Market conditions can change rapidly; investors should evaluate company fundamentals or consult their financial advisor before subscribing to any IPO.
FAQs
Q: What is the Rubicon Research IPO price band and lot size?
A: The price band for Rubicon Research IPO is ₹461 to ₹485 per share. The lot size is 30 shares, requiring a minimum investment of ₹14,550.
Q: What is the Rubicon Research IPO GMP today?
A: As per reports, Rubicon Research IPO GMP today is around ₹80, suggesting a possible listing price near ₹565 per share. However, GMP may fluctuate daily.
Q: How can I check my Rubicon Research IPO allotment status?
A: You can check allotment status on the registrar’s website or through your broker platform like Upstox or HDFC Securities once the allotment is announced.
